TrialJournal of aerosol medicine and pulmonary drug delivery2014

A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients.

A Bruce Montgomery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.